Chronic Inflammation (Inflammaging) and Its Potential Contribution to Age-Associated Diseases
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Human aging is characterized by a chronic, low-grade inflammation, and this phenomenon has been termed as "inflammaging." Inflammaging is a highly significant risk factor for both morbidity and mortality in the elderly people, as most if not all age-related diseases share an inflammatory pathogenesis. Nevertheless, the precise etiology of inflammaging and its potential causal role in contributing to adverse health outcomes remain largely unknown. The identification of pathways that control age-related inflammation across multiple systems is therefore important in order to understand whether treatments that modulate inflammaging may be beneficial in old people. The session on inflammation of the Advances in Gerosciences meeting held at the National Institutes of Health/National Institute on Aging in Bethesda on October 30 and 31, 2013 was aimed at defining these important unanswered questions about inflammaging. This article reports the main outcomes of this session.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although not every senescent cell develops a proapoptotic, inflammatory SASP, accumulation and persistence of such senescent cells can induce a chronic low-grade, pro-fibrotic inflammatory state (usually associated with aging and chronic diseases), known as ‘inflammaging’70.”
From Cellular senescence and senolytics: the path to the clinic (2022) · cites this paper as [70]
In the citing paper
“SASP factors mediate developmental senescence (Mun ˜ oz-Espı ´n et al., 2013; Storer et al., 2013), wound healing (Demaria et al., 2014), and tissue plasticity (Mosteiro et al., 2016) and also contribute to persistent chronic inflammation (known as inflammaging) (Franceschi and Campisi, 2014).”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Franceschi and Campisi, 2014
In the citing paper
“Chronic inflammation, often referred to as inflammaging (Franceschi and Campisi 2014), underlies many age-related pathologies.”
From Senescence and the SASP: many therapeutic avenues (2020) · cites this paper as Franceschi and Campisi 2014
In the citing paper
“Senescent cells create an aged-like inflamed niche that mirrors inflammation associated with ageing (inflammageing4) and arrests stem cell proliferation and regeneration.”
From Senescence atlas reveals an aged-like inflamed niche that blunts muscle regeneration (2023) · cites this paper as [4]
In the citing paper
“During ageing, tissue regenerative functions decline, in part due to stem cell-intrinsic accumulation of damage (for example, DNA damage, loss of proteostasis and oxidative damage), functional decay of niche cells and increased inflammation (inflammageing)4–9 through uncharacterized mechanisms.”
From Senescence atlas reveals an aged-like inflamed niche that blunts muscle regeneration (2023) · cites this paper as [4]
18 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Inflamm‐aging: An Evolutionary Perspective on Immunosenescence
FRANCESCHI, C., BONAFÈ, M., VALENSIN, S., OLIVIERI, F., DE LUCA, M., OTTAVIANI, E., & DE BENEDICTIS, G. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06651.x · Cited by 5,358 · cited 2×
““Inflammaging” describes the low-grade, chronic, systemic inflammation in aging, in the absence of overt infection (“sterile” inflammation), and is a highly significant risk factor for both morbidity and mortality in the elderly people (1).”
BackgroundSelf-citationThe senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206 · cited 2×
“Elimination of senescent cells in prematurely aged mice prevents several age-related pathologies (14).”
BackgroundSelf-citationImaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441 · cited 2×
“Mechanistically, senescent cells likely fuel age-related disease because they secrete numerous proinflammatory cytokines (termed the senescenceassociated secretory phenotype or SASP) that modify the tissue microenvironment and alter the function of nearby normal or transformed cells (12,13).”
BackgroundSelf-citationCirculating mitochondrial DAMPs cause inflammatory responses to injury
Zhang, Q., Raoof, M., Chen, Y., Sumi, Y., Sursal, T., Junger, W., Brohi, K., Itagaki, K., & Hauser, C. J. (2010) · Nature · doi:10.1038/nature08780 · Cited by 3,812 · cited 1×
“Mitochondria as phylogenetically bacterial symbionts of early eukaryotic cells, when damaged, release mitochondrial damage-associated molecular patterns (formyl peptides and mitochondrial DNA) with evolutionarily conserved similarities to bacterial pathogen-associated molecular patterns, which are released into the ci…”
BackgroundClearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 2×
“On the horizon, agents that eliminate senescent cells, or suppresses their SASP, hold promise for diminishing chronic inflammation caused by these cells since their clearance in a transgenic mouse model ameliorated several age-related pathologies (albeit in an accelerated aging mouse) (13).”
BackgroundRejuvenation of aged progenitor cells by exposure to a young systemic environment
Conboy, I. M., Conboy, M. J., Wagers, A. J., Girma, E. R., Weissman, I. L., & Rando, T. A. (2005) · Nature · doi:10.1038/nature03260 · Cited by 2,287 · cited 1×
“Three prominent examples are the ability of a young blood supply to rejuvenate tissue repair in aged skeletal muscle (25) and the capability of young serum to rejuvenate the proliferative and differentiation capacity of human muscle stem cells (satellite cells) from old donors (26), the ability of systemic GDF11 (grow…”
BackgroundDiabetes mellitus and the risk of dementia: The Rotterdam Study
Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A. P., Hofman, A., & Breteler, M. M. B. (1999) · Neurology · doi:10.1212/wnl.53.9.1937 · Cited by 2,175
Franceschi, C., Capri, M., Monti, D., Giunta, S., Olivieri, F., Sevini, F., Panourgia, M. P., Invidia, L., Celani, L., Scurti, M., et al. (2007) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2006.11.016 · Cited by 2,087 · cited 4×
“Consequently, in some individuals, such as many centenarians, inflammaging may develop more slowly or be restricted or balanced by anti-inflammatory responses that are less prominent in the general population (21).”
BackgroundInfluentialSelf-citationFour faces of cellular senescence
Rodier, F., & Campisi, J. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201009094 · Cited by 2,070 · cited 1×
“several possible mechanisms of chronic inflammation: (i) persistent production of reactive molecules by infiltrating leukocytes designed to kill pathogens, eventually damages the structural and cellular elements of tissues; (ii) damaged nonimmune cells and activated immune cells lead to the production of cytokines tha…”
BackgroundSelf-citationCellular senescence and the senescent secretory phenotype: therapeutic opportunities
Tchkonia, T., Zhu, Y., van Deursen, J., Campisi, J., & Kirkland, J. L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64098 · Cited by 1,774 · cited 1×
“Preventive and therapeutic Strategies On the horizon, agents that eliminate senescent cells, or suppress their SASP, hold promise for diminishing chronic inflammation caused by these cells (38).”
BackgroundSelf-citationPhysical activity and risk of cognitive decline: a meta-analysis of prospective studies
Sofi, F., Valecchi, D., Bacci, D., Abbate, R., Gensini, G. F., Casini, A., & Macchi, C. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02281.x · Cited by 1,210
Fat tissue, aging, and cellular senescence
Tchkonia, T., Morbeck, D. E., Von Zglinicki, T., Van Deursen, J., Lustgarten, J., Scrable, H., Khosla, S., Jensen, M. D., & Kirkland, J. L. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00608.x · Cited by 1,094 · cited 1×
“Senescent cells accumulate to especially high levels in adipose tissue, particularly the visceral fat of obese individuals (15).”
BackgroundThe role of exercise and PGC1α in inflammation and chronic disease
Handschin, C., & Spiegelman, B. M. (2008) · Nature · doi:10.1038/nature07206 · Cited by 1,083
Freund, A., Patil, C. K., & Campisi, J. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.69 · Cited by 1,039 · cited 6×
“NF-κB, for example, regulates the majority of genes that comprise the SASP (31).”
BackgroundInfluentialSelf-citation(2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.9.1069 · Cited by 988
Loffredo, F. S., Steinhauser, M. L., Jay, S. M., Gannon, J., Pancoast, J. R., Yalamanchi, P., Sinha, M., Dall’Osso, C., Khong, D., Shadrach, J. L., et al. (2013) · Cell · doi:10.1016/j.cell.2013.04.015 · Cited by 948 · cited 1×
“Three prominent examples are the ability of a young blood supply to rejuvenate tissue repair in aged skeletal muscle (25) and the capability of young serum to rejuvenate the proliferative and differentiation capacity of human muscle stem cells (satellite cells) from old donors (26), the ability of systemic GDF11 (grow…”
BackgroundMitochondrial Cardiolipin Is Required for Nlrp3 Inflammasome Activation
Iyer, S. S., He, Q., Janczy, J. R., Elliott, E. I., Zhong, Z., Olivier, A. K., Sadler, J. J., Knepper-Adrian, V., Han, R., Qiao, L., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.08.001 · Cited by 931 · cited 1×
“Cardiolipin, which is found only in mitochondria and bacteria, upon mitochondrial dysfunction can act as an endogenous pathogen-associated molecular pattern capable of activating the proinflammatory pathway of Nlrp3 inflammasome (11).”
BackgroundHypothalamic programming of systemic ageing involving IKK-β, NF-κB and GnRH
Zhang, G., Li, J., Purkayastha, S., Tang, Y., Zhang, H., Yin, Y., Li, B., Liu, G., & Cai, D. (2013) · Nature · doi:10.1038/nature12143 · Cited by 834 · cited 2×
“Moreover, NF-κB has been shown to drive several aging phenotypes, particularly in the skin, spine, and brain (28,32,33).”
BackgroundMechanisms of sodium pump regulation
Therien, A. G., & Blostein, R. (2000) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2000.279.3.c541 · Cited by 765
Interleukin-6 in Aging and Chronic Disease: A Magnificent Pathway
Maggio, M., Guralnik, J. M., Longo, D. L., & Ferrucci, L. (2006) · The Journals of Gerontology: Series A · doi:10.1093/gerona/61.6.575 · Cited by 692 · cited 1×
“IL-6 is arguably the most prominent cytokine that is shared across age-related pathologies having a strong chronic inflammatory component (29).”
BackgroundCanonical Nlrp3 Inflammasome Links Systemic Low-Grade Inflammation to Functional Decline in Aging
Youm, Y.-H., Grant, R. W., McCabe, L. R., Albarado, D. C., Nguyen, K. Y., Ravussin, A., Pistell, P., Newman, S., Carter, R., Laque, A., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.09.010 · Cited by 674 · cited 1×
“In a mouse model, reduction in the Nlrp3 inflammasome-dependent proinflammatory cascade attenuated age-related degenerative changes across multiple organs (39).”
BackgroundAging of the innate immune system
Shaw, A. C., Joshi, S., Greenwood, H., Panda, A., & Lord, J. M. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.05.003 · Cited by 647
Franceschi, C., Bonafè, M., & Valensin, S. (2000) · Vaccine · doi:10.1016/s0264-410x(99)00513-7 · Cited by 495
Self-citationMotif module map reveals enforcement of aging by continual NF-κB activity
Adler, A. S., Sinha, S., Kawahara, T. L. A., Zhang, J. Y., Segal, E., & Chang, H. Y. (2007) · Genes & Development · doi:10.1101/gad.1588507 · Cited by 466
Bollrath, J., & Greten, F. R. (2009) · EMBO reports · doi:10.1038/embor.2009.243 · Cited by 383 · cited 1×
“Among the transcription factors that regulate chronic inflammation across multiple diseases and tissues there are the NF-κB (nuclear factor kappa-light-chainenhancer of activated B cells) and STAT (signal transducer and activator of transcription) proteins (30).”
BackgroundInflammaging as a Major Characteristic of Old People: Can It Be Prevented or Cured?
Franceschi, C. (2008) · Nutrition Reviews · doi:10.1111/j.1753-4887.2007.tb00358.x · Cited by 342 · cited 1×
“Conclusions and Take Home Message “Inflammaging” describes the low-grade chronic inflammation in aging and is a highly significant risk factor for both morbidity and mortality in the elderly people, but it can be prevented and cured (36).”
BackgroundSelf-citationImmunosenescence: what does it mean to health outcomes in older adults?
McElhaney, J. E., & Effros, R. B. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.05.023 · Cited by 340
The network and the remodeling theories of aging: historical background and new perspectives
Franceschi, C., Valensin, S., Bonafè, M., Paolisso, G., Yashin, A. I., Monti, D., & De Benedictis, G. (2000) · Experimental Gerontology · doi:10.1016/s0531-5565(00)00172-8 · Cited by 335 · cited 1×
“However, as damage accumulates, the danger responses can become chronic and hence maladaptive (4).”
BackgroundSelf-citationAging of the Immune System as a Prognostic Factor for Human Longevity
Larbi, A., Franceschi, C., Mazzatti, D., Solana, R., Wikby, A., & Pawelec, G. (2008) · Physiology · doi:10.1152/physiol.00040.2007 · Cited by 320 · cited 1×
“Inflammatory stimuli and cytokines and the “immune risk profile” were found to be independent risk factors for survival (6) and immune risk profile resulted associated with IL-6 (7).”
BackgroundSelf-citationInflammaging as a Major Characteristic of Old People: Can It Be Prevented or Cured?
Franceschi, C. (2007) · Nutrition Reviews · doi:10.1301/nr.2007.dec.s173-s176 · Cited by 308
Self-citationWikby, A., Nilsson, B.-O., Forsey, R., Thompson, J., Strindhall, J., Löfgren, S., Ernerudh, J., Pawelec, G., Ferguson, F., & Johansson, B. (2006) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2006.04.003 · Cited by 285 · cited 8×
“More recently, these data were further strengthened as levels of IL-6 and soluble tumor necrosis factor-α R1 were identified as predictors of 10-year all-causes mortality (8).”
BackgroundInfluentialVaradhan, R., Yao, W., Matteini, A., Beamer, B. A., Xue, Q.-L., Yang, H., Manwani, B., Reiner, A., Jenny, N., Parekh, N., et al. (2014) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glt023 · Cited by 273 · cited 2×
“More recently, these data were further strengthened as levels of IL-6 and soluble tumor necrosis factor-α R1 were identified as predictors of 10-year all-causes mortality (8).”
BackgroundOxidative stress and the ageing endocrine system
Vitale, G., Salvioli, S., & Franceschi, C. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.29 · Cited by 270 · cited 1×
“It is also clear that reactive oxygen species production following mitochondrial dysfunction, DNA damage and DNA damage response and cell senescence are major players in this scenario (37).”
BackgroundSelf-citationThe role of inflammation in age-related disease
Howcroft, T. K., Campisi, J., Louis, G. B., Smith, M. T., Wise, B., Wyss-Coray, T., Augustine, A. D., McElhaney, J. E., Kohanski, R., & Sierra, F. (2013) · Aging · doi:10.18632/aging.100531 · Cited by 239 · cited 1×
“How Do Local and Systemic Sources of Chronic Inflammation Contribute to Chronic Disease Processes? Circulating proinflammatory molecules are strong predictors of age-related morbidity and mortality (8,22).”
BackgroundSelf-citationN-glycomic biomarkers of biological aging and longevity: A link with inflammaging
Dall’Olio, F., Vanhooren, V., Chen, C. C., Slagboom, P. E., Wuhrer, M., & Franceschi, C. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2012.02.002 · Cited by 231 · cited 2×
“Damaged cellular and organelle components, free radicals from oxidative stress, metabolites such as extracellular ATP, fatty acids, urate crystals, ceramides, cardiolipin, amyloid, succinate, peroxidized lipids, advanced glycation end-products, altered N-glycans (3), and HMGB1 are recognized by a network of sensors (i…”
BackgroundSelf-citationMicroRNAs linking inflamm-aging, cellular senescence and cancer
Olivieri, F., Rippo, M. R., Monsurrò, V., Salvioli, S., Capri, M., Procopio, A. D., & Franceschi, C. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2013.05.001 · Cited by 205 · cited 1×
“These include regulation at the levels of transcription and translation, as well as regulation by micro-RNAs (34), posttranslational modifications, and regulated secretion (including processing by the inflammasome).”
BackgroundSelf-citationMechanisms of disease: inflammasome activation and the development of type 2 diabetes
Grant, R. W., & Dixit, V. D. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00050 · Cited by 203 · cited 1×
“Fat is another rich source of inflammatory cytokines and major changes in fat distribution and lipid composition and function may have profound clinical consequences linked to several age-related disorders (16).”
BackgroundThe aging gut microbiota: New perspectives
Biagi, E., Candela, M., Franceschi, C., & Brigidi, P. (2011) · Ageing Research Reviews · doi:10.1016/j.arr.2011.03.004 · Cited by 128 · cited 1×
“A second source of inflammaging might be represented by harmful products produced by the microbial constituents of the human body, such as oral or gut microbiota, which can leak into surrounding tissues and the circulation (5).”
BackgroundSelf-citationAge-dependent alteration in muscle regeneration: the critical role of tissue niche
Barberi, L., Scicchitano, B. M., De Rossi, M., Bigot, A., Duguez, S., Wielgosik, A., Stewart, C., McPhee, J., Conte, M., Narici, M., et al. (2013) · Biogerontology · doi:10.1007/s10522-013-9429-4 · Cited by 119
Self-citationBonafè, M., Storci, G., & Franceschi, C. (2012) · BioEssays · doi:10.1002/bies.201100104 · Cited by 94 · cited 1×
“This notion is perhaps most prominently illustrated by the case of the niches surrounding malignant tumors (23).”
BackgroundSelf-citationNasto, L. A., Seo, H.-Y., Robinson, A. R., Tilstra, J. S., Clauson, C. L., Sowa, G., Ngo, K., Dong, Q. D., Pola, E., Lee, J. Y., et al. (2012) · Spine · doi:10.1097/brs.0b013e31824ee8f7 · Cited by 90
Adriaensen, W., Derhovanessian, E., Vaes, B., Van Pottelbergh, G., Degryse, J.-M., Pawelec, G., Hamprecht, K., Theeten, H., & Matheï, C. (2015) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glu018 · Cited by 41
Inflammaging: should this term be suitable for age related macular degeneration too?
Gallenga, C. E., Parmeggiani, F., Costagliola, C., Sebastiani, A., & Gallenga, P. E. (2013) · Inflammation Research · doi:10.1007/s00011-013-0684-2 · Cited by 32 · cited 1×
“Finally, defective or inappropriate regulation of the complement pathway can lead to local inflammatory reactions in age-related macular degeneration, the leading cause of blindness in the elderly people (20).”
BackgroundThe Multifactorial Nature of Retinal Vascular Disease
Kleinman, M. E., Baffi, J., & Ambati, J. (2010) · Ophthalmologica · doi:10.1159/000315152 · Cited by 24 · cited 1×
“Likewise, the local (tissue) cytokine milieu is an important driver of age-related retinal vascular disease (24), and there is evidence that the SASP of damaged or senescent cells can disrupt local tissue structures and function (12,14).”
BackgroundSong, W. K., Yang, W. I., Byeon, S. H., Koh, H. J., Kwon, O. W., & Lee, S. C. (2009) · Ophthalmologica · doi:10.1159/000233231 · Cited by 13
Research works printed but not linked: 2
- 2014, The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 69, 165
- 2013, 4, 50
Cited by
Inflammaging: a new immune–metabolic viewpoint for age-related diseases
Franceschi, C., Garagnani, P., Parini, P., Giuliani, C., & Santoro, A. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0059-4 · Cited by 3,586
Self-citationCellular Senescence: Defining a Path Forward
Gorgoulis, V., Adams, P. D., Alimonti, A., Bennett, D. C., Bischof, O., Bishop, C., Campisi, J., Collado, M., Evangelou, K., Ferbeyre, G., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.005 · Cited by 3,225
“SASP factors mediate developmental senescence (Mun˜oz-Espı´n et al., 2013; Storer et al., 2013), wound healing (Demaria et al., 2014), and tissue plasticity (Mosteiro et al., 2016) and also contribute to persistent chronic inflammation (known as inflammaging) (Franceschi and Campisi, 2014).”
BackgroundSelf-citationFibrosis: from mechanisms to medicines
Henderson, N. C., Rieder, F., & Wynn, T. A. (2020) · Nature · doi:10.1038/s41586-020-2938-9 · Cited by 1,868
Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype
Kumari, R., & Jat, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.645593 · Cited by 1,622
NAD+ metabolism and its roles in cellular processes during ageing
Covarrubias, A. J., Perrone, R., Grozio, A., & Verdin, E. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00313-x · Cited by 1,617
Metadata
- Authors
- Franceschi, C., & Campisi, J.
- Affiliations
- University of Bologna (IT)
- Buck Institute for Research on Aging (US)
- Venue
- The Journals of Gerontology Series A: Biological Sciences and Medical Sciences
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-05-14
- Volume
- 69
- Issue
- Suppl 1
- Pages
- S4-S9
- ISSN
- 1079-5006 (ISSN-L)
- 1758-535X
- OpenAlex
- W2129155846
- Cited by
- 3,891
- References
- 41
- Citations by year
- 2026: 363 · 2025: 416 · 2024: 375 · 2023: 386 · 2022: 375 · 2021: 440 · 2020: 380 · 2019: 336 · 2018: 300 · 2017: 240 · 2016: 167 · 2015: 93 · 2014: 15
- FWCI
- 19.12
- Type
- journal article
- Language
- en
- Open access
- Licence
- other-oa
- Locations
- The Journals of Gerontology Series A (publishedVersion)
- PubMed (publishedVersion)
- INFM-OAR (INFN Catania) (submittedVersion, other-oa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- inflammaging, low-grade inflammation, aging, age-related diseases, anti-inflammatory therapy
- MeSH terms
- Aging, Chronic Disease, Geriatrics, Humans, Inflammation, Morbidity, Risk Factors, Global Health, Biomarkers, Cytokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.